We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors

    Pituitary neuroendocrine tumors (PitNETs) exhibiting aggressive, treatment-refractory behavior are the rare subset that progress after surgery,...

    Andrew L. Lin, Vasilisa A. Rudneva, ... Viviane Tabar in Acta Neuropathologica
    Article Open access 17 May 2024
  2. P53 loss of heterozygosity (LOH) in formalin-fixed paraffin-embedded leiomyosarcoma (LMS): a novel report

    Background

    The occurrence of p53 loss of heterozygosity (LOH) is a common genetic event in malignancy. LOH occurs when a heterozygous locus loses one...

    John N. McMahon, Eoin F. Gaffney, ... Bernadette Curran in Irish Journal of Medical Science (1971 -)
    Article 20 July 2023
  3. Compound Heterozygosity for Late-Onset Cardiomyopathy-Causative ALPK3 Coding Variant and Novel Intronic Variant Cause Infantile Hypertrophic Cardiomyopathy

    Hypertrophic and dilated cardiomyopathy (HCM, DCM) are leading causes of cardiovascular morbidity and mortality in children. The pseudokinase...

    Tomer Poleg, Marina Eskin-Schwartz, ... Moti Haim in Journal of Cardiovascular Translational Research
    Article 16 November 2023
  4. Drivers of genomic loss of heterozygosity in leiomyosarcoma are distinct from carcinomas

    Leiomyosarcoma (LMS) is a rare, aggressive, mesenchymal tumor. Subsets of LMS have been identified to harbor genomic alterations associated with...

    Nathan D. Seligson, Joy Tang, ... James L. Chen in npj Precision Oncology
    Article Open access 25 April 2022
  5. Synchronous thyroid cancer and malignant struma ovarii: concordant mutations and microRNA profile, discordant loss of heterozygosity loci

    Background

    Struma ovarii is an unusual ovarian teratoma containing predominantly thyroid tissue. Less than 10% of cases undergo malignant...

    Gabriella T. Seo, Jeremy Minkowitz, ... Sydney D. Finkelstein in Diagnostic Pathology
    Article Open access 18 April 2023
  6. Characteristics of Chinese breast cancer patients with double heterozygosity for BRCA1 and BRCA2 germline pathogenic variants

    Purpose

    Despite of very rare, breast cancer patients with double heterozygosity (DH) variants in BRCA1 and BRCA2 genes have been identified in other...

    Song Wen, Meng Zhang, ... Yuntao **e in Breast Cancer Research and Treatment
    Article 20 June 2024
  7. Cerebral venous thrombosis with hyperhomocysteinemia due to loss of heterozygosity at methylenetetrahydrofolate reductase (MTHFR) locus: a case report

    Background

    Loss of heterozygosity (LOH) at methylenetetrahydrofolate reductase ( MTHFR ) locus has been reported in tumor tissue. But the mutation was...

    Mingjie Zhang, Bingxin Shi, Mangsuo Zhao in BMC Neurology
    Article Open access 19 April 2023
  8. CFTR heterozygosity in severe asthma with recurrent airway infections: a retrospective review

    Rationale

    Patients with asthma who have neutrophilic bronchitis may have an underlying cause leading to increased susceptibility to airway infections.

    ...
    Eldar Priel, Adil Adatia, ... Parameswaran Nair in Allergy, Asthma & Clinical Immunology
    Article Open access 06 June 2022
  9. Myxoid pleomorphic liposarcoma is distinguished from other liposarcomas by widespread loss of heterozygosity and significantly worse overall survival: a genomic and clinicopathologic study

    Myxoid pleomorphic liposarcoma (MPLPS) is a recently described and extremely rare subtype of liposarcoma with a predilection for the mediastinum....

    Josephine K. Dermawan, Sinchun Hwang, ... Cristina R. Antonescu in Modern Pathology
    Article 07 June 2022
  10. The first case of intellectual disability caused by novel compound heterozygosity for NUDT2 variants

    NUDT2 is an enzyme important for maintaining the intracellular level of the diadenosine tetraphosphate (Ap4A). Bi-allelic loss of function variants...

    Bo Bi, **aohong Chen, ... Yangcan Ming in BMC Pediatrics
    Article Open access 19 January 2024
  11. Verification of a loss of heterozygosity at the D8S1179 locus in a paternity case by the MiSeq FGx system

    Capillary electrophoresis is widely used to study short tandem repeats (STRs) in forensic genetics. However, next-generation sequencing platforms...

    Yequan Wang, **udi Hou, ... Zhen Dang in International Journal of Legal Medicine
    Article 20 June 2023
  12. CALR loss-of-heterozygosity as a potential driver for extramedullary AML

    Marie-Christine Weller, Eugenia Haralambieva, ... Stefan Balabanov in Annals of Hematology
    Article 26 September 2022
  13. Compound heterozygosity for hemoglobin S and hemoglobin E in a family of Proto-Australoid origin: a case report

    Background

    Hemoglobin S and E are commonly occurring hemoglobin variants among distinctly separate tribal populations of Central and Northeast India,...

    Noymi Basumatary, Dipankar Baruah, ... Jatin Sarmah in Journal of Medical Case Reports
    Article Open access 02 August 2021
  14. Clinical relevance of double heterozygosity revealed by next-generation sequencing of homologous recombination repair pathway genes in South African breast cancer patients

    Purpose

    Genetically predisposed breast cancer (BC) patients represent a minor but clinically meaningful subgroup of the disease, with 25% of all cases...

    Nerina C. van der Merwe, Ines Buccimazza, ... Jaco Oosthuizen in Breast Cancer Research and Treatment
    Article Open access 30 May 2024
  15. Congenital adrenal hyperplasia caused by compound heterozygosity of two novel CYP11B1 gene variants

    Background

    Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder caused by pathogenic variants in seven genes involved in the...

    I. Fylaktou, P. Smyrnaki, ... Ch. Kanaka-Gantenbein in Hormones
    Article 26 October 2021
  16. Compound heterozygosity for two novel mutations of the SEC23B gene in congenital dyserythropoietic anemia type II

    Congenital dyserythropoietic anemia type II (CDA II), a rare genetic disorder, results from SEC23B gene mutations according to previous studies....

    Shanshan Chen, Ziwen Guo, ... Guinian Huang in International Journal of Hematology
    Article 29 April 2021
  17. Low heterozygosity for rs3811050, a 5 prime untranslated region variant of the gene encoding interleukin-38 (IL1F10), is associated with a reduced risk of systemic lupus erythematosus

    Background

    Interleukin-38 (IL-38), an inflammatory cytokine discovered in recent years, has been implicated in the pathogenesis of systemic lupus...

    Rawan A. Nijeeb, Adnan A. Aljber, Ali H. Ad’hiah in Egyptian Journal of Medical Human Genetics
    Article Open access 21 March 2024
  18. Double heterozygosity for TP53 and BRCA1 mutations: clinical implications in populations with founder mutations

    Purpose

    The co-occurrence or double heterozygosity of pathogenic/likely pathogenic sequence variants (P/LPSVs) in major cancer susceptibility genes...

    Hagit Shani, Rinat Bernstein-Molho, ... Eitan Friedman in Breast Cancer Research and Treatment
    Article 15 January 2021
  19. Idiopathic hypogonadotropic hypogonadism caused by compound heterozygosity for two novel mutations in the GNRH1 gene: a case report

    Background

    Idiopathic hypogonadotropic hypogonadism (IHH) is a rare congenital or acquired genetic disorder caused by gonadotropin-releasing hormone...

    Qingqing Tian, **g**g Tang, ... Zhufang Tian in BMC Endocrine Disorders
    Article Open access 05 October 2023
Did you find what you were looking for? Share feedback.